Find out why these oncology-focused companies stand out as great opportunities right now.
News & Analysis: Blueprint Medicines
BPMC earnings call for the period ending December 31, 2018.
Canopy Growth Corporation, MyoKardia, and Blueprint Medicines are all outstanding healthcare picks this month.
Why Array BioPharma, Deciphera Pharmaceuticals, and Blueprint Medicines Are Up by Double Digits Today
Shares of all three cancer-focused companies shot higher after one of their peers got bought out for a sizable premium.
Investors flocked to the clinical-stage biotech following an encouraging second-quarter update.
News from key competitors sent this company's shares reeling.
The biopharma reported encouraging data from a phase 1 trial. Er, wait, what?
These stocks may yet grow into multibaggers with a little more time.